CUSTIRSEN SODIUM Drug Record

  • CUSTIRSEN SODIUM chembl:CHEMBL2219773 Antineoplastic

    Alternate Names:

    CUSTIRSEN SODIUM
    OGX-011
    ISIS-112989

    Drug Info:

    Pharmaceutical Developer OncoGenex
    Source Reported Drug Name(s) OGX-011/custirsen
    Drug Class CLU Inhibitor
    FDA Approval not approved
    Drug Class antisense oligo
    Drug Indications antineoplastic agent
    (0 More Sources)

    Publications:

  • CUSTIRSEN SODIUM   CLU

    Interaction Score: 41.22

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Novel drug target Novel Target
    Trial Name OGX-011
    Reported Cancer Type Prostate

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial CancerCommons

  • CancerCommons: OGX-011

    • Version: 25-July-2013

    Alternate Names:
    CHEMBL2103801 PubChem Drug Name
    70689314 PubChem Drug ID
    Custirsen Drug Trade Name

    Drug Info:
    Drug Class CLU Inhibitor
    Source Reported Drug Name(s) OGX-011/custirsen
    Pharmaceutical Developer OncoGenex

    Publications:

  • TdgClinicalTrial: OGX-011

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class antisense oligo
    FDA Approval not approved

    Publications:

  • ChemblDrugs: chembl:CHEMBL2219773

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: